Tests short, targeted radiation after surgery for endometrial cancer
Tests targeted radiation after surgery in adults with endometrial cancer.
Plain-language title generated from the registry record
Registry title: a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial Cancer
Key facts
- Where
- Palermo, ItalySee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT06360653, who can take part
Where in Italy
- ARNAS Civico HospitalPalermo, ItalyNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- ARNAS Civico Di Cristina Benfratelli Hospital
- Trial code
- NCT06360653
- Record updated
- 25 June 2025
- Original description
The primary endpoint of the present prospective study is to assess the outcomes in terms of acute toxicity of post-operative stereotactic radiotherapy for endometrial cancerRead full original descriptionShow less
a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial Cancer (SISTER-RAY)
The primary endpoint of the present prospective study is to assess the outcomes in terms of acute toxicity of post-operative stereotactic radiotherapy for endometrial cancer
Exclusion: Prior pelvic radiotherapy; Any diagnosis of inflammatory bowel disease (both active or quiescent); Para-aortic lymph nodes involvement; ECOG PS ≥ 3.
Age 18-80 years; ECOG PS ≤ 2 or KPS ≥ 70%; Patients diagnosed with endometrial cancer (endometrioid, serous cell, clear cell, carcinosarcoma) FIGO stage IB-IIIC1 candidate to post-operative external beam radiotherapy, based on molecular and histological findings; Indications for chemotherapy and/or brachytherapy are not exclusion criteria for the purpose of the study; Written Informed Consent.